The sigma receptor ligand 1,3-di-(2-tolyl)guanidine in animal models of schizophrenia.

Abstract

The behavioral effects of the selective sigma ligand 1,3-di(2-tolyl)guanidine (DTG) were studied in rats. In the radial 8-arm maze, DTG (2, 4 and 8 mg/kg i.p.) reduced the number of arm entries in the spontaneous alternation task. In animals receiving 4 mg/kg DTG, the percentage of 135 degrees angles between consecutive arm entries decreased. In the open field, equipped with a holeboard, DTG (8 mg/kg) reduced the number of line crossings, rearings and head dips. Sniffing, measured in an experimental chamber, was also reduced. DTG prolonged the time that the animals were inactive. In combination with DL-amphetamine (4 mg/kg) or dizocilpine (0.16 mg/kg), DTG (8 mg/kg) decreased--but did not antagonize--the induced enhancement of locomotion and sniffing. These results demonstrate motor depressant effects of DTG on locomotion, rearing and sniffing. Since antagonists of sigma binding sites are known to produce opposite effects, we conclude that DTG--in behavioral terms--acts like an antagonist at sigma binding sites.

• Authors: N G Rückert, W J Schmidt
• Journal: European journal of pharmacology (Eur J Pharmacol) Vol. 233 Issue 2-3 Pg. 261-7 (Mar 23 1993) ISSN: 0014-2999 [Print] Netherlands
• PMID: 8467871 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)

Chemical References

• Guanidines
• Receptors, sigma
• Dizocilpine Maleate
• Amphetamine
• 1,3-ditolylguanidine

Topics

• Amphetamine (pharmacology)
• Animals
• Behavior, Animal (drug effects)
• Binding Sites
• Dizocilpine Maleate (pharmacology)
• Guanidines (pharmacology)
• Male
• Models, Biological
• Motor Activity (drug effects)
• Rats
• Rats, Sprague-Dawley
• Receptors, sigma (metabolism)
• Schizophrenia (metabolism)